Sentinel Node Biopsy | Overview
Management of Stage III melanoma has evolved in recent years. With the advent of effective adjuvant therapy in treating Stage III melanoma, sentinel node biopsy (SNB) is essential for accurate clinical decision-making for clinicians. In this webinar, Surgical Oncologist Prof Andrew Spillane presents on the role of SNB, the current practice undertaken at Melanoma Institute Australia and the implications for adjuvant therapy.
CLICK HERE for Additional audience questions and answers
Prof Andrew Spillane
Surgical Oncologist, Melanoma Institute Australia | Professor of Surgical Oncology, The University of Sydney
1. Describe what is sentinel lymph node biopsy (SNB)
2. Describe the benefit of SNB for melanoma patients
3. Develop a systemic approach to SNB based on latest evidence and new upcoming adjuvant treatment options for clinically occult Stage III melanoma patients.
InformativeInformative and well executed